Case Report: Avelumab and ruxolitinib to manage polycythemia vera and secondary metastatic Merkel cell carcinoma: a possible successful combination

We describe a case of second primary malignancy in a 65-year-old patient affected by polycythemia vera treated with the JAK 1/2 inhibitor ruxolitinib. The latter is recognized as a risk factor for the onset of non-melanoma skin cancers in many retrospective and perspective studies, but the concomita...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Chiara Masucci, Mauro Passucci, Emilia Scalzulli, Ida Carmosino, Marcello Capriata, Alessandro Costa, Claudia Ielo, Maurizio Martelli, Massimo Breccia
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Frontiers Media S.A. 2023-06-01
Schriftenreihe:	Frontiers in Oncology
Schlagworte:	avelumab Merkel cell carcinoma ruxolitinib polycytemia vera second malignancies
Online-Zugang:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1212638/full
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!